Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  18F-fluoromisonidazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for Newly Diagnosed Stage IB, Stage II, Stage III, or Stage IV Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00257, CDR0000574114, UW-6143, UW IRB# 6143, 7958, N01CM37008, NCT00559377
MRI and PET Scan Using 18F-Fluoromisonidazole In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01912, CDR0000640413, ACRIN 6684, U01CA080098, NCT00902577
Evaluation of [18F]-FMISO for Non Operated Glioblastoma
Phase: Phase II
Type: Health services research
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUBX2008/31, NCT00906893
HYPONCO - Hypoxia in Brain Tumors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2009-015543-16, NCT01200134
Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 07-162, NCT00713037
Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUBX 2008/20, NCT01235052
Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy
Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 138725, NCT01967927
Start Over